top
Search terms
Results 1 - 10 of 33 - ordered by :
Pages: 1 2 3 4
Ehjcvp

Vice versa, patients presenting with acute coronary syndromes (ACS) develop AF in 621% of cases, hence, through the presence of vascular disease, these patients automatically require anticoagulation ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Miklos Rohla, Thomas W. Weiss, Johann Wojta, Alexander Niessner, Kurt Huber

Date : 01/07/2015 Item size : 293945 bytes
Ehjcvp

Effect of rapid desensitization on platelet inhibition and basophil activation in patients with aspirin hypersensitivity and coronary disease Cases were patients with coronary artery disease (CAD) ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Article, Stéphane Manzo-Silberman, Pascale Nicaise-Roland, Catherine Neukirch, Florence Tubach, Marie-Geneviève Huisse, Sylvie ...

Date : 05/08/2016 Item size : 209243 bytes
Ehjcvp

Introduction Dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a P2Y12 inhibitor, is recommended by guidelines for up to 12 months in patients with acute coronary ...

European Heart Journal - Cardiovascular Pharmacotherapy, Original Articles, Gianluigi Savarese, Stefano Savonitto, Lars H. Lund, Stefania Paolillo, Caterina Marciano, Santo Dellegrottaglie, Antonio ...

Date : 01/10/2016 Item size : 333679 bytes
Eurointervention

EuroIntervention Prolonged dual antiplatelet therapy: a potential mitigator of the adverse effects of local haemodynamic shear stress in high-risk coronary regions? Additionally, the benefits of ...

Date : 12/02/2016 Item size : 66621 bytes
Eurointervention

Ospedali Galliera, Genova, Italy Aims: Premature dual antiplatelet therapy (DAPT) interruption is associated with an increased risk of stent thrombosis and poor clinical outcomes after implantation ...

Date : 17/05/2011 Item size : 35394 bytes
Eurointervention

EuroIntervention Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing ...

Date : 20/06/2016 Item size : 103289 bytes
Ehjournal

[...]patients with renal insufficiency have a particularly high risk of coronary events, actually higher than that of most diabetic patients.2 Second, the interaction between renal failure and ...

European Heart Journal, Editorial, Nicolas Danchin, Etienne Puymirat, François Schiele

Date : 21/01/2016 Item size : 184766 bytes
Ehjcvp

Introduction Dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a P2Y12 inhibitor, is recommended by guidelines for up to 12 months in patients with acute coronary ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Gianluigi Savarese, Stefano Savonitto, Lars H. Lund, Stefania Paolillo, Caterina Marciano, Santo Dellegrottaglie, Antonio ...

Date : 21/04/2016
Heart

Stent thromboses are rare but potentially fatal complications after coronary stent implantation.2 Different factors have been identified that independently correlate with the risk for stent ...

Heart, Education in Heart, Helge Möllmann, Holger M Nef, Christian W Hamm

Date : 01/06/2010
Ehjournal

Dual antiplatelet therapy (DAPT) with aspirin and an ADP receptor antagonist is the foundation to prevent stent thrombosis (ST).1 Whereas drug-eluting stents (DES) are more effective than bare metal ...

European Heart Journal, Stone, Gregg W.

Date : 01/08/2014